The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNG.L Regulatory News (HNG)

  • There is currently no data for HNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Strategic Review

28 Nov 2018 17:55

RNS Number : 8289I
TLA Worldwide PLC
28 November 2018
 

 

28 November 2018

 

TLA Worldwide plc

("TLA" or "the Group")

 

Update on Strategic Review

 

 

Further to the announcement on 24 September 2018, TLA's subsidiary, TLA Acquisitions Limited has signed a letter of intent ("LOI") to sell the Group's US businesses (comprising both the baseball and US sports marketing businesses) to a fund managed by Gatemore Capital Management LLP ("Gatemore"). The sale is subject, inter alia, to due diligence and the execution of a definitive agreement by 3 December 2018 and if not, either party may terminate the LOI in its sole discretion. Following the sale, the US business will operate as a privately owned business.

 

The Group is now also actively considering the sale of its Australian businesses (comprising the Australian sports marketing business).

 

These disposals are expected to require Shareholder approval under AIM Rule 15. In addition, the potential sale of the US businesses to Gatemore will be treated in accordance with AIM Rule 13.

 

Whilst discussions with the various parties are continuing, the indications are that the sale proceeds from both the US and Australian businesses, after the full discharge of the bank debt held at subsidiary level, will leave a modest cash balance in TLA.

 

As definitive arrangements are agreed, further announcements will be made.

 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

 

TLA Worldwide

Ian Gray, Executive Chairman

+44 20 7618 9100

 

Beaumont Cornish Limited (Nomad and Broker)

Roland Cornish, James Biddle

+44 20 7628 3396

 

 

Luther Pendragon

Harry Chathli, Alexis Gore

+44 20 7618 9100

About TLA

 

TLA is a leading athlete representation, sports marketing and event management group quoted on London's AIM. The Group derives revenues from long term agency relationships with many prominent US and international sports stars, broadcasters and media personalities associated with major sports including the MLB, NFL, NBA, PGA TOUR, AFL, Olympians and cricketers. In addition, it also provides a range of services in respect of media consultancy, sports sponsorship and event creation and ownership. With over 170 full-time personnel, TLA serves its clients from 10 locations worldwide including its offices in London, UK; New York, Newport Beach, Houston, Charleston, San Francisco, USA; Melbourne, Perth, Adelaide and Sydney, Australia. For more information, please visit www.tlaworldwide.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
LOIFEUFWAFASELF
Date   Source Headline
9th Jan 20249:54 amRNSIntention to Delist
4th Jul 20234:31 pmRNSAppointment of voluntary liquidators
19th May 20236:07 pmRNSJoint Administrators' Application to Court
6th Apr 20237:00 amRNSJoint Administrators’ Statement of Proposals
13th Feb 20232:41 pmRNSAppointment of Joint Administrators
19th Dec 202212:20 pmRNSUpdate on Unsecured Convertible Loan Notes
12th Dec 20227:00 amRNSUpdate on Unsecured Convertible Loan Notes
2nd Dec 202210:13 amRNSUpdate on Unsecured Convertible Loan Notes
30th Nov 20224:41 pmRNSFurther update on Hawkwing loan to IFG (SPP)
28th Nov 20227:00 amRNSUpdate on Hawkwing’s CULS
27th Oct 20225:31 pmRNSFurther update on Hawkwing loan to IFG
26th Oct 20225:26 pmRNSUpdate on Hawkwing loan to IFG
12th Oct 20228:00 amRNSDirector Declaration
30th Sep 20225:50 pmRNSInterim Results
24th Jun 202212:25 pmRNSResult of Annual General Meeting
1st Jun 20224:45 pmRNSAnnual Report & Accounts 2021 and Notice of AGM
1st Jun 20227:00 amRNSFinal Results
11th Feb 20227:45 amRNSChange of Auditor
24th Dec 20217:00 amRNSRelisting
13th Dec 20217:00 amRNSIFG withdrawal from heads of terms
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20217:00 amRNSHawkwing loans IFG £13.7 million for acquisitions
16th Sep 20217:00 amRNSUpdate on Hawkwing loan to IFG
12th Aug 20217:00 amRNSHawkwing raises £16.5 million
12th Jul 20217:50 amRNSPotential Acquisition and Suspension of Listing
29th Apr 202111:48 amRNSResult of AGM
7th Apr 20211:29 pmRNSAnnual Report & Accounts 2020 and Notice of AGM
6th Apr 20212:15 pmRNSFinal Results
9th Mar 20211:52 pmRNSHolding(s) in Company
18th Jan 202111:05 amRNSSecond Price Monitoring Extn
18th Jan 202111:00 amRNSPrice Monitoring Extension
18th Jan 20219:05 amRNSSecond Price Monitoring Extn
18th Jan 20219:00 amRNSPrice Monitoring Extension
14th Oct 20207:00 amRNSInterim Results
5th Oct 20205:27 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSHolding(s) in Company
30th Sep 20204:53 pmRNSHolding(s) in Company
30th Sep 202010:48 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSAdmission to Standard List
29th Sep 20205:30 pmRNSHawkwing
23rd Sep 20201:28 pmRNSPublication of Prospectus
26th Aug 20207:00 amRNSUpdate on Move to Standard List of the Main Market
12th Aug 20207:00 amRNSUpdate on Move to Standard List of the Main Market
1st Jul 202011:01 amRNSPlacing to raise approximately £1.3m
29th Jun 20202:31 pmRNSResult of AGM and General Meeting
12th Jun 20205:09 pmRNSProposed admission to the Main Market
4th Jun 20202:56 pmRNSAnnual Report & Accounts 2019 and Notice of AGM
4th Jun 20207:00 amRNSFinal Results
6th Mar 20207:30 amRNSSuspension - Hawkwing Plc
6th Mar 20207:00 amRNSSuspension of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.